SignalMacro

ZENTALIS PHARMACEUTICALS ( NASDAQ : ZNTL ) ISSUES EARNINGS RESULTS , BEATS EXPECTATIONS BY $0.24 EPS

Zentalis beat EPS expectations by $0.24, a positive earnings catalyst.

What changed

Zentalis beat EPS expectations by $0.24, a positive earnings catalyst.

Why it matters

Zentalis beat EPS expectations by $0.24, a positive earnings catalyst. — impact context not separately stored; see What changed.

Sources